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Background: Unintentional drug overdose has increased markedly in the past two decades and surpassed motor
vehicle crashes as the leading cause of injury mortality in many states. The purpose of this study was to understand
the trajectory of the drug overdose epidemic in the United States by applying Farr’s Law. Farr’s “law of epidemics”
and the Bregman-Langmuir back calculation method were applied to United States drug overdose mortality
data for the years 1980 through 2011 to project the annual death rates from drug overdose from 2012
through 2035.
Findings: From 1980–2011, annual drug overdose mortality increased from 2.7 to 13.2 deaths per 100,000 population.
The projected drug overdose mortality would peak in 2016–2017 at 16.1 deaths per 100,000 population and then
decline progressively until reaching 1.9 deaths per 100,000 population in 2035.
Conclusion: The projected data based on Farr’s Law suggests that drug overdose mortality in the United States will
decline in the coming years and return to the 1980 baseline level approximately by the year 2034.
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In mid-nineteenth century England, William Farr, one of
the founders of modern epidemiology, analyzed mortal-
ity rates attributed to a smallpox outbreak and derived a
“law of epidemics” from the observed patterns, postulat-
ing that the dynamics of epidemic outbreaks generally
follow a symmetric curve (Farr 1840). Since that time,
the theory that became known as “Farr’s Law” has been
applied to projecting the trajectories of the 1885 cattle
plague epidemic (Brownlee 1915a), the 1901 outbreak of
smallpox (Brownlee 1915b), and the AIDS epidemic
(Bregman and Langmuir 1990), with mixed results.
More recently, several authors cited data that demon-
strate increases in drug overdose deaths over the past
decade (Johnson et al. 2014; Jones et al. 2013) or longer
(Unick et al. 2013). Such observations precipitated inter-
ventions aimed at limiting opportunities for abuse of
controlled substances, particularly prescription opioids.* Correspondence: GL2240@cumc.columbia.edu
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in any medium, provided the original work is pTwo of these interventions, the expansion of Prescrip-
tion Drug Monitoring Programs (PDMPs) across the
United States and increased availability and training on
rescue treatments that reverse an opioid overdose, have
coincided with the stabilization of the annual death rate
due to opioid overdoses since 2007 (Brady et al. 2014).
Opioid analgesics account for approximately two thirds
of the total drug overdose mortality (CDC 2011). Tem-
poral trends in drug overdoses closely follow those in
prescription drug consumption: as the morphine kilo-
gram equivalents per capita increase, so does the rate of
drug overdose mortality. Likewise, both measures began
to plateau in 2007 (Brady et al. 2014). This observation
motivated our hypothesis that the drug overdose epi-
demic is leveling off, and the mortality from drug over-
dose should start to decline soon and eventually return
to a baseline level. Underlying this hypothesis is the
fundamental principle of Farr’s Law: epidemics follow a
natural sequence in which they spread and subside in a
pattern that approximates a symmetric curve (Bregman
and Langmuir 1990). Our objective is to apply Farr’s
Law to the drug overdose epidemic and to evaluate over
the next several years whether our projections hold true.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Annual number of deaths and mortality rate per
100,000 population from unintentional drug overdose in
the United States, 1980–2011, with projections to 2035
Year Deathsa First Ratiob Second Ratioc Deaths per 100,000
1980 6094 2.8
1981 6227 1.0218 2.8
1982 6299 1.0116 0.9900 2.8
1983 6445 1.0232 1.0115 2.8
1984 6723 1.0431 1.0195 2.9
1985 7082 1.0534 1.0098 3.0
1986 7969 1.1252 1.0682 3.3
1987 7920 0.9939 0.8832 3.3
1988 9031 1.1403 1.1473 3.7
1989 9275 1.0270 0.9007 3.7
1990 8413 0.9071 0.8832 3.4
1991 9392 1.1164 1.2308 3.7
1992 10604 1.1290 1.0114 4.1
1993 12133 1.1442 1.0134 4.7
1994 12714 1.0479 0.9158 4.8
1995 12779 1.0051 0.9592 4.8
1996 13227 1.0351 1.0298 4.9
1997 14445 1.0921 1.0551 5.3
1998 15315 1.0602 0.9708 5.5
1999 16849 1.1002 1.0377 6.0
2000 17415 1.0336 0.9395 6.2
2001 19394 1.1136 1.0774 6.8
2002 23518 1.2126 1.0889 8.2
2003 25785 1.0964 0.9041 8.9
2004 27424 1.0636 0.9701 9.4
2005 29813 1.0871 1.0221 10.1
2006 34425 1.1547 1.0622 11.5
2007 36010 1.0460 0.9059 12.0
2008 36450 1.0122 0.9677 12.0
2009 37004 1.0152 1.0029 12.1
2010 38329 1.0358 1.0203 12.4
2011 41340 1.0786 1.0413 13.3
2012 44035 1.0652 0.9876 14.1
2013 46323 1.0520 0.9876 14.9
2014 48127 1.0389 0.9876 15.4
2015 49380 1.0260 0.9876 15.8
2016 50038 1.0133 0.9876 16.1
2017 50076 1.0008 0.9876 16.1
2018 49493 0.9883 0.9876 15.9
2019 48310 0.9761 0.9876 15.5
2020 46570 0.9640 0.9876 14.9
2021 44336 0.9520 0.9876 14.2
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2022 41686 0.9402 0.9876 13.4
2023 38709 0.9286 0.9876 12.4
2024 35498 0.9171 0.9876 11.4
2025 32150 0.9057 0.9876 10.3
2026 28757 0.8945 0.9876 9.2
2027 25403 0.8834 0.9876 8.2
2028 22162 0.8724 0.9876 7.1
2029 19095 0.8616 0.9876 6.1
2030 16248 0.8509 0.9876 5.2
2031 13654 0.8404 0.9876 4.4
2032 11332 0.8299 0.9876 3.6
2033 9288 0.8196 0.9876 3.0
2034 7519 0.8095 0.9876 2.4
2035 6011 0.7994 0.9876 1.9
a2011 United States population is used to calculate the annual number of
deaths projected for 2012–2035.
bPercent increase in the mortality rate from the previous year, calculated as
deaths in the current year/deaths in the previous year. For example, from 1981
to 1982 the mortality rate increased by a factor of 1.0116 (=6299/6227). Since
1980 is the baseline for this analysis, its first ratio is undefined.
cAcceleration (rate of change) of the first ratio, calculated as first ratio for the
current year/first ratio for the previous year. For example, from 1981 to 1982
the acceleration in the mortality rate was 0.9900 (=1.0116/1.0218). The second
ratios for 1980–1981 are undefined. The second ratio for 2011–2035 is chosen
as the mean of the five second ratios for 2007, 2008, 2009, 2010, and 2011.
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A drug overdose epidemic curve for the United States
was generated by combining observed mortality rates
(1980–2011) with mortality rates projected for 2012–
2035 following the principles of Farr’s Law. For the ob-
served period (1980–2011), data came from the National
Center for Health Statistics (Warner et al. 2011). Through
1998, unintentional drug overdose deaths were classified
using the International Classification of Diseases, Ninth
Revision, and included underlying cause of death codes:
E850–E858, E950.0–E950.5, E962.0, and E980.0–E980.5.
Starting in 1999, deaths were classified using the Inter-
national Classification of Diseases, Tenth Revision, and
included underlying cause of death codes: X40–X44,
X60–X64, X85, and Y10–Y14. Crude annual drug poison-
ing mortality rates were calculated using the annual popu-
lation for the years observed and the 2011 population for
the rates projected for 2012–2035 (CDC WONDER 2014).
For future projections on the number of drug overdose
deaths expected under the principles of Farr’s Law, we
applied the method described by Bregman and Langmuir
(1990) and calculated two ratios: 1) the percent increase
in the mortality rate for each year of observed data, and
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To fit a symmetric curve, we took the mean acceleration
(=0.9876) for the last five years of observed data (2007–
2011), and extrapolated the first ratio followed by the
number of deaths expected if the principles of Farr’s
Law hold for the drug overdose epidemic.Findings
The annual number of deaths from drug overdoses,
along with the percent increase (first ratio) and the
acceleration (second ratio) over the previous year are
displayed in Table 1. In general, the number of drug
overdose deaths in the United States increased progres-
sively from 1980 through 2011. The second ratio indi-
cates that the sharpest annual increases in mortality
occurred during the last 10 years of the observed period
(in 2000–2001, 2001–2002, and 2005–2006), whereas
the relative stability of the first ratio from 2007–2010
indicates a plateau in the number of deaths toward the
end of the observed timeframe. Using the mean acceler-
ation for those five years, the projected annual mortality
for 2012–2034 steadily declines to 2.4 deaths per
100,000 population, which is similar to the 1980 base-
line rate of 2.7 deaths per 100,000 population (Figure 1).
Mortality projections for 2011–2035 based on Farr’s
Law approximate the right half of a symmetric curve,
although our calculations estimate that the rate will de-
crease from its peak in 2016–2017 to the 1980 baseline
level in 18 years, approximately half of the time the rate
took to peak.Figure 1 Annual mortality from drug overdose in the United States 1
(grey data points).Discussion
Our projections based on Farr’s Law indicate that drug
overdose mortality in the United States will decrease
from its peak in 2016–2017 to the 1980 baseline level in
about 18 years. Our projections are made under the as-
sumption that the United States drug overdose epidemic
is nearing its peak, as suggested by recent mortality data
and opioid prescription data (Brady et al. 2014; Li et al.
2014). The shape of the drug overdose mortality curve
depends on two key elements: 1) the constant (i.e., the
second ratio) chosen for approximating the symmetric
curve; and 2) the population count used to calculate the
mortality rate. Our decision to use 0.9876 as the second
ratio constant was derived from synthesizing information
about annual per capita consumption of opioid analgesics
and the observed mortality rate accelerations, both of
which indicate a shift around 2007 in that opioid sales and
deaths stabilized thereafter. The more controversial choice
in our projected calculations is the population denomin-
ator. Initially, we used the annual population data from
the United States Census Bureau in an attempt to factor
changes in the number of people at risk. The mortality
curve initially generated under the assumption of a dy-
namic (i.e., increasing) population very closely resembled
the one presented in Figure 1. However, since the popula-
tion susceptible to drug overdose may remain relatively
stable in the projected 24-year period, with adults aging
both into and out of the highest risk group (45–54 year-
olds) (Warner et al. 2011), we opted for a more conserva-
tive method and approximated overdose mortality rates
based on the 2011 United States population.980–2011, with projections through 2035 based on Farr’s Law
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trajectory of the epidemic of drug overdose deaths in the
United States. Although this epidemic has been studied
extensively through statistical models using predictive
variables (Dasgupta et al. 2012; Li et al. 2014; Paulozzi
and Stier 2010), we are unaware of any previous study
predicting the trajectory of a non-infectious epidemic
using Farr’s Law. Our projections, if partially accurate,
may help assess intermediate outcomes to gauge
whether interventions are working and guide long-term
planning and management of public health resources and
prevention efforts. When access to prescription medica-
tion becomes more difficult with enforcement of PDMPs,
there is a hazard of diversion whereby people shift to
using alternative substances such as heroin. To avoid this
substitution effect would require multifaceted interven-
tions such as the expansion of prescription limits, in-
creased drug screening, requiring pain contracts, and the
distribution of naloxone to first responders.
There are several limitations to our study. First, this is
a crude approximation of an epidemic curve based on
assumptions that guided our choices of the acceleration
constant and population at risk. Although the method
we applied originated from studies of infectious diseases,
it is unknown whether Farr’s Law applies to epidemics
of a non-infectious origin. It is plausible that a non-
communicable disease, such as drug overdose, can follow
infectious patterns. Indeed, a theory of social contagion
has been proposed for a myriad of behavioral disorders
(Eisenberg et al. 2013) as well as obesity (Christakis and
Fowler 2007), albeit with some controversy in the latter
example. As with behavioral disorders, the social mechan-
ism of transmission may underlie drug-use initiation, con-
tinuation, and transition such that those activities then
mimic infectious disease patterns, proliferating through
the population until some natural threshold or interven-
tion prevents further spread. Second, for simplicity, we es-
timated drug overdose mortality for the projection period
without considering changes in the size of the population
or the age distribution of the population. This may bias
our estimates somewhat because the United States popu-
lation is projected to gradually grow in size and get older
in age composition. Furthermore, these results are limited
to overdose mortality data and are for the United States as
a whole. Thus, the results may not reflect trends in non-
fatal drug overdose incidents and in specific geographic
areas. Despite these limitations, the predicted epidemic
curve guided by Farr’s Law suggests that annual drug
overdose mortality is likely to decline in the coming years
and probably return to the baseline level by the year 2034.
Conclusions
Mortality data over the next two decades will ultimately
test the accuracy of our projections. If the drugoverdose epidemic is indeed waning, it may imply that
the intensified efforts in recent years, such as enhanced
prescription drug monitoring, are working and should
be continued.
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